| This webinar provided an overview of NOL poison pills, including the purposes and benefits of an NOL poison pill, key provisions and mechanics of an NOL poison pill, how an NOL poison pill differs from a traditional antitakeover poison pill, trends in the adoption of NOL poison pills, key considerations in determining whether to adopt an NOL poison pill rather than a traditional antitakeover poison pill, steps to implement an NOL poison pill, corporate governance and proxy advisory firm issues, and relevant judicial precedent. |
About the Morgan Lewis shareholder activism defense practice |
| Morgan Lewis's nationally recognized shareholder activism defense practice is ranked near the top of most of the major league tables for activist defense law practices based on the number of publicly disclosed activism defense situations we have been involved in during the relevant period. Our shareholder activism defense practice advises public companies across the United States and abroad in a wide array of industries with respect to preparing for and/or responding to high-profile proxy contests, special meeting demands, consent solicitations, withhold and vote-no campaigns, shareholder proposals, and other activist shareholder campaigns as well as contests for corporate control and contested M&A situations. Our shareholder activism defense practice also advises on the latest techniques for lessening a company’s vulnerability to activist shareholders, strategic communications, shareholder engagement strategies, board composition enhancement programs, and corporate governance matters. |
|
|
 |
| PRESENTERS |
 |
Keith E. Gottfried
Corporate partner and shareholder activism defense practice leader,
Morgan Lewis
|
 |
Sean M. Donahue
Corporate partner, shareholder activism defense practice,
Morgan Lewis |
|
